Last reviewed · How we verify
NCT03115775: TM
CLA and Vitamin D on Protein Turnover
NA trial testing Conjugated linoleic acid in Protein in 40 participants. Completed in 31 August 2019.
31 August 2019
Quick facts
| Lead sponsor | Washington University School of Medicine |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | other |
| Enrollment | 40 |
| Start date | 12 May 2017 |
| Primary completion | 31 August 2019 |
| Estimated completion | 31 August 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Conjugated linoleic acid — full drug profile →
- Vitamin D
- Conjugated linoleic acid and Vitamin D
- Corn oil (placebo)
Conditions studied
- Protein — all drugs for Protein →
Sponsor
Washington University School of Medicine
Who can join
Adults 65 to 85, any sex, with Protein. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To conduct a randomized, double-blind, controlled clinical trial to determine the independent and combined effects of dietary conjugated linoleic acid (CLA) and vitamin D supplementation on anabolic signaling, the expression of growth regulatory factors, and muscle protein turnover in older adults.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
No independent or combined effects of vitamin D and conjugated linoleic acids on muscle protein synthesis in older adults: a randomized, double-blind, placebo-controlled clinical trial.
van Vliet S, Fappi A, Reeds DN, Mittendorfer B. · · 2020 · cited 14× · PMID 32860399 · DOI 10.1093/ajcn/nqaa240
Verify or expand the search:
- PubMed search for NCT03115775
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Conjugated linoleic acid
Trials testing the same drug.
- NCT04641494 — The Effect of CLA on Obesity, Lung Functions, Lipid Profile and Inflammation in Women With BMI≥25 · NA · completed
Other recruiting trials for Protein
Currently open trials in the same condition.
- NCT06427018 — Expressions of Ezrin and Pip5k1α Proteins in Airway Smooth Muscle of Asthmatic Patients · recruiting
- NCT05296096 — PRotein Optimization With eXercise to Improve MUscle Mass and Functional outcomeS · NA · recruiting
Other Washington University School of Medicine trials
Trials by the same sponsor.
- NCT05521997 — Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer · Phase 2 · not yet recruiting
- NCT07101666 — Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer · Phase 2 · not yet recruiting
- NCT07200089 — Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel) · Phase 1 · not yet recruiting
- NCT07313592 — Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients · not yet recruiting
- NCT07419464 — 5-Fluorouracil Response and Optimization STudy (The FROST Trial) · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03115775 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Washington University School of Medicine
- Last refreshed: 21 November 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03115775.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing